Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 5, 2023Virtual Press Office and PR Newswire: General Trade show news
Kahoot! ASA, the global learning and engagement platform company, will host a virtual Investor Day on Wednesday June 7, 2023 beginning at 15:00 CEST/09:00 EST/06:00 PST or applicable. Kahoot! ASA...
-
Jun 5, 2023Virtual Press Office and PR Newswire: General Trade show news
Mr. Samuel Sang, vice president of EVE Energy, delivered a keynote speech on the green and low-carbon manufacturing of lithium batteries and carbon reduction strategies at the 2nd China...
-
Jun 5, 2023Virtual Press Office and PR Newswire: General Trade show news
New Gateway Delivers Longer Range, Lower Power Consumption and Enhanced RF Performance for IoT Networks TAIPEI, June 5, 2023 /PRNewswire/ -- COMPUTEX 2023 -- AsiaRF, a leading wireless...
-
Jun 4, 2023Virtual Press Office and PR Newswire: General Trade show news
Vial, a global tech-first CRO providing next-generation clinical trial management services, announced it will be sponsoring and presenting at the 2023 Clinical Trials at the Summit (CTS) in Park...
-
Jun 4, 2023Virtual Press Office and PR Newswire: General Trade show news
alliantgroup was created to support the growth and innovation of small to medium-sized businesses, providing them with the same level of consulting services available to large corporations....
-
Jun 4, 2023Virtual Press Office and PR Newswire: General Trade show news
While the incidence of colorectal cancer (CRC) has dropped significantly among older adults in recent years — a trend attributed to regular screening colonoscopies and lower smoking rates —...
-
Jun 3, 2023Virtual Press Office and PR Newswire: General Trade show news
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX FASPRO® combination biweekly regimen showed an overall response rate of more than 80 percent...
-
Jun 3, 2023Virtual Press Office and PR Newswire: General Trade show news
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of TECVAYLI® (teclistamab-cqyv), a first-in-class BCMAxCD3...
-
Jun 3, 2023Virtual Press Office and PR Newswire: General Trade show news
– PRGN-2009 combined with an investigational checkpoint inhibitor resulted in a 30% ORR in patients with heavily pre-treated HPV-associated cancers that were naïve or resistant to checkpoint...
-
Jun 3, 2023Virtual Press Office and PR Newswire: General Trade show news
-- Breadth of pipeline featured in multiple early clinical data presentations, reflecting diversity of fundamental growth drivers across development programs -- CAMBRIDGE, Mass., June 3, 2023...